IRIS

Sfoglia per Rivista  DIABETES CARE

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 20 di 31
Titolo Data di pubblicazione Autore(i) File
A 5-year (1989-1993) prospective study of the incidence of IDDM in Rome and the Lazio region in the age-group 0-14 years 1-gen-1996 Sebastiani, L; Visalli, N; Adorisio, E; Suppa, Ma; Buzzetti, R; Decicco, Al; Giovannini, C; Comerci, Md; Negri, M; Pozzilli, P
ACUTE ONSET OF SEEMING IDDM IN AN AIDS PATIENT 1-gen-1992 Pozzilli, P; Buzzetti, R; Dotta, F; Andreani, D
Adult- Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7 1-gen-2014 Hawa, Mi; Kolb, H; Schloot, N; Beyan, H; Paschou, Sa; Buzzetti, R; Mauricio, D; De Leiva, A; Yderstraede, K; Beck-Neilsen, H; Tuomilehto, J; Sarti, C; Thivolet, C; Hadden, D; Hunter, S; Schernthaner, G; Scherbaum, Wa; Williams, R; Brophy, S; Pozzilli, P; Leslie, Rd
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype Action LADA 7 1-gen-2013 Hawa, Mi; Kolb, H; Schloot, N; Beyan, H; Paschou, Sa; Buzzetti, R; Mauricio, D; De Leiva, A; Yderstraede, K; Beck-Neilsen, H; Tuomilehto, J; Sarti, C; Thivolet, C; Hadden, D; Hunter, S; Schernthaner, G; Scherbaum, Wa; Williams, R; Brophy, S; Pozzilli, P; Leslie, Rd
Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients 1-gen-1999 Medici, F; Hawa, Mi; Giorgini, A; Panelo, A; Solfelix, Cm; Leslie, Rdg; Pozzilli, P
Autoantibody reversion: Changing risk categories in multiple-autoantibody– positive individuals. 1-gen-2020 Alhamar, G. E.; Strollo, R.; Pozzilli, P
Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult) - Definition, characterization and potential prevention 1-gen-2001 Pozzilli, P; Di Mario, U
beta-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults 1-gen-2008 Cernea, S; Buzzetti, R; Pozzilli, P
Breast-Feeding and Childhood-Onset Type 1 Diabetes A pooled analysis of individual participant data from 43 observational studies 1-gen-2012 Cardwell, Cr; Stene, Lc; Ludvigsson, J; Rosenbauer, J; Cinek, O; Svensson, J; Perez-Bravo, F; Memon, A; Gimeno, Sg; Wadsworth, Ejk; Strotmeyer, Es; Goldacre, Mj; Radon, K; Chuang, Lm; Parslow, Rc; Chetwynd, A; Karavanaki, K; Brigis, G; Pozzilli, P; Urbonaite, B; Schober, E; Devoti, G; Sipetic, S; Joner, G; Ionescu-Tirgoviste, C; de Beaufort, Ce; Harrild, K; Benson, V; Savilahti, E; Ponsonby, Al; Salem, M; Rabiei, S; Patterson, Cc
COFFEE OR SUGAR - WHICH IS TO BLAME IN IDDM? 1-gen-1991 Pozzilli, P; Bottazzo, Gf
COMBINATION OF NICOTINOMIDE OND STEROID VERSUS NICOTINAMIDE IN RECENT-ONSET IDDM - THE IMDIAB-II STUDY 1-gen-1994 Pozzilli, P; Visalli, N; Boccuni, Ml; Baroni, Mg; Buzzetti, R; Fioriti, E; Signore, A; Cavallo, Mg; Andreani, D; Lucentini, L; Matteoli, Mc; Crino, A; Cicconetti, Ca; Teodonio, C; Amoretti, R; Pisano, L; Pennafina, Mg; Santopadre, G; Marozzi, G; Multari, G; Campea, L; Suppa, Ma; Demattia, Gc; Faldetta, Mc; Marietti, G; Perrone, F; Greco, Av; Ghirlanda, G
Computed tomography highlights increased visceral adiposity associated with critical illness in covid-19 1-gen-2020 Battisti, S.; Pedone, C.; Napoli, N.; Russo, E.; Agnoletti, V.; Nigra, S. G.; Dengo, C.; Mughetti, M.; Conte, C.; Pozzilli, P; Giampalma, E.; Strollo, R.
Diabetes, incidence in 0-to 14-year age-group in Italy - A 10-year prospective study 1-gen-2004 Carle, F; Gesuita, R; Bruno, G; Coppa, Gv; Falorni, A; Lorini, R; Martinucci, Me; Pozzilli, P; Prisco, F; Songini, M; Tenconi, Mt; Cherubini, V
Evaluation of Long- Term Treatment Effect in a Type 1 Diabetes Intervention Trial: Differences After Stimulation With Glucagon or a Mixed Meal 1-gen-2014 Pozzilli, P; Raz, I; Peled, D; Elias, D; Avron, A; Tamir, M; Eren, R; Dagan, S; Cohen, Ir
Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis - Response to Lecube et al. 1-gen-2006 Vespasiani Gentilucci, U; Picardi, A; Pozzilli, P
Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11 1-gen-2016 Schloot, Nc; Pham, Mn; Hawa, Mi; Pozzilli, P; Scherbaum, Wa; Schott, M; Kolb, H; Hunter, S; Schernthaner, G; Thivolet, C; Seissler, J; Leslie, Rd; Action LADA, Group
Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes? 1-gen-2013 Mannucci, E; Dicembrini, I; Lauria, A; Pozzilli, P
Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes 1-gen-2014 Aronson, R; Gottlieb, Pa; Christiansen, Js; Donner, Tw; Bosi, E; Bode, Bw; Pozzilli, P
Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM 1-gen-1996 Pozzilli, P; Browne, Pd; Kolb, H
Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3 1-gen-2009 Hawa, Mi; Thivolet, C; Mauricio, D; Alemanno, I; Cipponeri, E; Collier, D; Hunter, S; Buzzetti, R; de Leiva, A; Pozzilli, P; Leslie, Rdg
Mostrati risultati da 1 a 20 di 31
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile